One of the most common dangers encountered when using an immunosuppressive agent is the predisposition of the patient to various types ofinfections. It has been thought that this was in inevitable risk that had to be considered when using immunosuppressants.
Frentizole, a benzimidazoleurea of low acute toxicity, has been previously reported to be a potent immunosuppressant (3) . Frentizole given subcutaneously to mice, at 2 mg/kg in 10 daily doses, is capable of suppressing both antibody response, measured by antibody to sheep erythrocytes, and T cell activity (graft-versushost reaction) (R. L. Stone, F. N. Wolfe, C. G. Cublertson, and C. J. Paget, Fed. Proc., p. 333, 1976) . Comparable immunosuppressive activity was achieved with azathioprine at doses of 100 mg/kg in 10 daily doses (2) . Frentizole markedly extended the mean survival time of NZBxW mice (up to 147%) (Stone et al., Fed. Proc., p. 333, 1976 (Table 2 and Fig. la-c) compared to the saline controls at all drug treatment levels. Azathioprine at 100 mg/kg (an immunosuppressive dose) and at 50 mg/kg decreased the median survival time by 56 and 48%, respectively. The mean survival time with 50 and 100 mg of Frentizole per kg was greater than twice that with azathioprine at 50 and 100 mg/ kg ( Table 2) .
The mean survival time of specific-pathogenfree male mice (12 to 14 g) pretreated with Frentizole or azathioprine at 100, 50, or 25 mg/ kg and infected with herpes simplex virus was reduced. Azathioprine, however, at 100 mg/kg resulted in a significant decrease of 48% (P < 0.005) in the median survival time (2.8 ± 0.3 days) compared to Frentizole at the same dose level (5.4 ± 0.6 days) (Fig. 2a-c) .
Frentizole-and azathioprine-treated mice were approximately equally susceptible to influenza at all dose levels (Fig. 3a-c) . At the 100-mg/kg dose level, there was a significant decrease (P < 0.005) in mean survival time by approximately 30% compared to the saline control group. If, however, the effects of the drugs at equally suppressive dose levels are compared, Frentizole at 25 mg/kg (12.5 and its immunosuppressive dose) did not predispose the mice to influenza, whereas azathioprine at its immunosuppressive dose of 100 mg/kg did result in a significant decrease in mean survival time of influenza virus-infected mice.
DISCUSSION
The results of this study indicate that Frentizole, a novel immunosuppressive agent even at super-immunosuppressive doses (50 times that dose necessary to inhibit antibody formation to sheep erythrocytes), did not predispose to bacterial, viral, or fungal infections, as did azathioprine. Compared to azathioprine, Frentizole at equally immunosuppressive doses may in fact, in some instances, protect against infection (see Table 1 and Fig. 1 
